Helmerich & Payne Financial Statements (HP)

Helmerich & Paynesmart-lab.ru   2025Q3 2025Q4 2026Q1 2026Q2   LTM ?
Report date 11.08.2025 21.11.2025 05.02.2026 07.05.2026   07.05.2026
Currency USD USD USD USD   USD
Financial report URL  
Revenue, bln rub ? 1 041 1 012 1 017 932.4   4 002
Operating Income, bln rub -128.3 22.7 44.0 -12.4   -74.0
EBITDA, bln rub ? 75.8 154.8 123.8 168.3   522.6
Net profit, bln rub ? -162.8 -57.4 -97.2 -58.6   -375.9
OCF, bln rub ? 121.6 207.0 182.4 36.6   547.6
CAPEX, bln rub ? 97.0 64.1 67.6 62.9   291.6
FCF, bln rub ? 24.6 142.8 114.9 -26.3   256.0
Dividend payout, bln rub 25.2 25.2 25.2 0.000   75.6
Ordinary share dividend yield, % 0.00% 0.00% 0.00% 0.00%   0.00%
Dividend payout ratio, % 0.00% 0.00% 0.00% 0.00%   -20.1%
OPEX, bln rub 285.5 85.2 77.1 78.1   525.9
Cost of production, bln rub 883.7 903.8 896.0 866.7   3 550
R&D, bln rub 7.78 7.57 6.65 7.02   29.0
Interest expenses, bln rub 29.2 28.0 25.6 25.8   108.6
Assets, bln rub 6 862 6 706 6 459 6 336   6 336
Net Assets, bln rub ? 2 764 2 725 2 603 2 529   2 529
Debt, bln rub 2 192 2 320 2 033 2 002   2 002
Cash, bln rub 187.4 245.8 269.0 224.7   224.7
Net debt, bln rub 2 004 2 074 1 764 1 778   1 778
Ordinary share price, rub 15.2 22.1 28.7 36.0   39.9
Number of ordinary shares, mln 99.4 99.4 99.3 99.9   99.9
Market cap, bln rub 1 506 2 197 2 847 3 599   3 988
EV, bln rub ? 3 511 4 271 4 611 5 376   5 765
Book value, bln rub 2 104 2 056 1 957 1 901   1 901
EPS, rub ? -1.64 -0.58 -0.98 -0.59   -3.76
FCF/share, rub 0.25 1.44 1.16 -0.26   2.56
BV/share, rub 21.2 20.7 19.7 19.0   19.0
EBITDA margin, % ? 7.28% 15.3% 12.2% 18.0%   13.1%
Net margin, % ? -15.6% -5.67% -9.55% -6.29%   -9.39%
FCF yield, % ? 2.43% 5.31% 6.31% 7.11%   6.42%
ROE, % ? -1.12% -6.01% -12.1% -14.9%   -14.9%
ROA, % ? -0.45% -2.44% -4.89% -5.93%   -5.93%
P/E ? -48.8 -13.4 -9.02 -9.57   -10.6
P/FCF 41.2 18.8 15.9 14.1   15.6
P/S ? 0.44 0.59 0.70 0.90   1.00
P/BV ? 0.72 1.07 1.45 1.89   2.10
EV/EBITDA ? 4.76 6.48 7.89 10.3   11.0
Debt/EBITDA 2.72 3.15 3.02 3.40   3.40
R&D/CAPEX, % 8.02% 11.8% 9.84% 11.2%   9.95%
CAPEX/Revenue, % 9.32% 6.34% 6.64% 6.74%   7.29%
Helmerich & Payne shareholders